Immunotherapy Nusantara is an individual immune therapy based on dendritic cells derived from the patient's blood. These immune cells are processed in a laboratory to recognize cancer cells or pathogens, then reinjected into the patient to enhance the imm

Lieutenant General TNI (Ret.) Prof. Dr. (H.C.) dr. Terawan Agus Putranto, Sp.Rad(K) is an Indonesian doctor and former military officer, former Minister of Health of the Republic of Indonesia (2019–2020), and previously served as Head of RSPAD Gatot S

The process includes:

• Collecting white blood cells (specifically monocytes) from the patient.
• Activating the cells in a laboratory with specific antigens to recognize cancer cells or viruses.
• Injecting the activated dendritic cells back into the pa

This therapy:

• Strengthens the immune system to detect and fight serious diseases such as cancer, diabetes, or autoimmune diseases.
• As a personalized therapy, it uses the patient's own cells to minimize side effects and enhance effectivene

This therapy is suitable for:

• Patients with cancer (early to advanced stages).
• Patients with autoimmune diseases (under doctor supervision).
• Patients with chronic infections such as hepatitis or prolonged symptoms from COVID-19 (with sp

The procedural steps include:

1. Collecting a blood sample from the patient.
2. Processing immune cells in a laboratory for 7 days to produce active dendritic cells.
3. Injecting the dendritic cells intradermally (under the skin).
4. Monitoring the patie

The cost of a single therapy session is IDR 15,015,000. Currently, this therapy is not covered by BPJS as it is still categorized as research-based therapy.

This therapy is generally safe as it uses the patient's own cells, minimizing the risk of rejection. Possible mild side effects include:

• Mild fever.
• Redness or pain at the injection site.
• Temporary fatigue.

This therapy is available at:

• RSPAD Gatot Soebroto (Central Jakarta)
• Klinik Utama Simas Sehat Sejahtera (Central Jakarta)
• RS Karang Tengah Medika (Tangerang)
• RS Bhayangkara (Surabaya)
• RS Slamet Riyadi (Solo)
• Bali Immunotherapy Center
• Medan

The therapy's effectiveness varies depending on the individual and factors like lifestyle. Patients can evaluate the need for repeat therapy, with a minimum interval of 1 months after the previous injection.

Yes, this therapy can be used as a complement after chemotherapy or radiation, depending on the patient's health condition as assessed by a doctor.

The results of the therapy vary between individuals but can generally be evaluated within 1–3 months after the therapy.

This therapy is a research-based therapy in Indonesia, with limited ethical approval and strict medical supervision. Currently, it is not a national standard treatment.

Preparation includes:

• Consultation with a doctor.
• Comprehensive health examination.
• Blood sample collection for dendritic cell isolation.

Yes, you can have a consultation before starting the therapy, and currently there is no charge.